21 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 Jun 21
Current report (foreign)
7:38am
to Planet Financial Performance Values-Based Governance Global Corporate Social Responsibility Legal Disclaimers Appendix Reconciliations 03 06 08 09 … , more than 60% of our research and development (R&D) pipeline is being developed with partners around the world. We have 16 Global Corporate Social Responsibility Program
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
28 May 21
Current report (foreign)
6:01am
workplaces. Takeda’s ESG commitment – including its Access to Medicines strategy and Global Corporate Social Responsibility Program – is evident through
6-K
e2e8 c39kg4t60u
11 May 21
Current report (foreign)
6:08am
6-K
EX-99.1
lbkxv2a8
17 Dec 20
Current report (foreign)
6:01am
6-K
8fjk5f 6z78ubwfdt
29 Jul 20
Current report (foreign)
6:07am
6-K
EX-1
fv8zh
27 May 20
Current report (foreign)
6:03am
6-K
i4r1t5h6lb7nak28
13 May 20
Current report (foreign)
6:03am
6-K
af6govtjtj
14 Jan 20
Current report (foreign)
6:56am
6-K
EX-99.1
iuyog5 p6nh8ixrmfxm
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
6-K
EX-99.1
00sv cpqk
14 Nov 19
Current report (foreign)
6:26am
424B3
193qi1bcjg mg8
14 Nov 19
Prospectus supplement
6:10am
F-4/A
5e1szcvz0iiy
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
cqxyky0b4cc1
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
aldem7ulb6y
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
1udz8gyahjtmuww9
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
8iq of7nd863wdxs
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am